P2X7 and inflammatory fingerprinting of patients with carotid atherosclerosis and the risk of abdominal aortic aneurysm
Authors:
Open Access
- 7 November 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Abstract
Co-presentation of carotid plaque (CPL) and abdominal aortic aneurysm (AAA) is frequent and synergy in the development proposed. Inflammatory mediators affect this growth but their interplay in inducing single or multiple vascular damage scarcely explored. Healthy people and characterized male patients undergoing aneurysmectomy or endarterectomy with significant/not significant CPL and large AAA or no/small AAA were allocated to groups. CPL distribution along the carotid branches differed in patients without vs. with large AAA. ELISA and 15plex Luminex assays in serum and lesioned arteries revealed intergroup differences in the content of P2X7, GM-CSF, CXCL1, IL-1β, IL-10, IL-12p70, CCL 3, TNFα, and RT-qPCR in the expression of P2X7-targeting microRNA, namely miR-150. These data identified group-distinctive inflammatory fingerprints, stratifying patients. In silico analysis of fingerprints showed GO processes common/exclusive to groups, supporting mechanistic difference associated to lesion presentation. In vitro aortic endothelial cells respond to serum from patients with both AAA and CPL but not with only CPL, increasing P2X7, IL1B and CXCL1 genes and P2X7 isoforms, hinting to a relation between serum fingerprints and artery type. Fingerprinting may represent a stratifying tool for patients with CPL and AAA; P2X7, GM-CSF, IL-1β and CXCL1 emerge as potential candidates for personalized monitoring and therapy.Keywords
Funding Information
- Ministero della Salute (RCR-2022-23682288)
This publication has 64 references indexed in Scilit:
- Macrophage polarization and metabolic reprogramming in abdominal aortic aneurysmImmunity, Inflammation and Disease, 2024
- A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonistsNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- MicroRNA: Crucial modulator in purinergic signalling involved diseasesPurinergic Signalling, 2022
- Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic AneurysmsInflammation, 2022
- P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Mortality from abdominal aortic aneurysm: trends in European Union 15+ countries from 1990 to 2017British Journal of Surgery, 2020
- The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progressionPurinergic Signalling, 2017
- P2X7 Receptor as a Therapeutic Target2016
- Distribution of macrophage polarization markers in human atherosclerosisAtherosclerosis, 2012
- Generalized ArteriomegalyArchives of Surgery, 1981